Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)

0 Saves · 3 Shares · 1 Comments Discussion

Grant Name

Funder

HHS-NIH11(National Institutes of Health)

Research Field

Food and Nutrition

Health

Deadline

October 7, 2022 (Expired)

Grant Size

$3,000,000

Contact Info

National Institutes of Health grantsinfo@nih.gov

Eligibility

Small businesses, Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Grant Number

RFA-DK-21-012

Description

This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of novel and supportive technologies for the improvement of cell replacement interventions using novel methods, biomaterials and devices for type 1 diabetes (T1D) treatment.

Website

http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-012.html

Funding resources
NIH General Instructions	Download File
NIH Application Guide	Open Link
Purdue Grant Writing Lab: Introduction to Grant Writing	Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	Open Link